General MedicationsORALGeneric
DIDANOSINE
DIDANOSINE
Standard Dose
10MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview DIDANOSINE is listed in Drugs@FDA under application 078112 (ANDA).
Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength FOR SOLUTION;ORAL - 10MG/ML Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2012-01-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview DIDANOSINE is listed in Drugs@FDA under application 078112 (ANDA). Marketing status: Discontinued Active ingredient DIDANOSINE Form and strength FOR SOLUTION;ORAL - 10MG/ML Sponsor AUROBINDO PHARMA Submission history Latest submission status date: 2012-01-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.